VANCOUVER, BC, June 4, 2026 /PRNewswire/ - Advancing into its third year, Wheaton Precious Metals™ Corp. ("Wheaton" or the "Company") is pleased to announce the...
VANCOUVER, BC, June 4, 2026 /CNW/ - Advancing into its third year, Wheaton Precious Metals™ Corp. ("Wheaton" or the "Company") is pleased to announce the...
TORONTO, June 04, 2026 (GLOBE NEWSWIRE) -- Lysander Funds Limited (“Lysander”), the manager of Canso Credit Income Fund (the “Fund”) (TSX: PBY.UN), announces that, at the special meeting of unitholders of the Fund held on June 4, 2026, unitholders of each class of the Fund have approved a change in the structure of the Fund from a closed-end fund into an exchange-traded fund (the “Conversion”), along with other related changes necessary to facilitate and implement the Conversion.
BMM: TSX-VVANCOUVER, BC, June 4, 2026 /CNW/ - Black Mammoth Metals Corporation (TSXV: BMM) (OTC: LQRCF) ("Black Mammoth" or the "Company") is pleased to announce...
CHARLOTTE, N.C., June 4, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) today announced that its Greenland operations team has...
CARSON CITY, Nev., June 4, 2026 /PRNewswire/ -- American Lithium Minerals, Inc. (OTC: AMLM) ("AMLM" or the "Company"), an exploration-stage mining company focused on...
Ethics Committee Approval Received for Pivotal Study Intended to Support U.S. FDA Class II Submission for QuickScan™ Strep AVANCOUVER, BC, June 4, 2026 /CNW/...
HONG KONG, June 04, 2026 (GLOBE NEWSWIRE) -- CoinEx has officially completed its fifth monthly CET repurchase and burning event of 2026, continuing its long-standing commitment to transparent token management and sustainable ecosystem development.
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).
CALGARY, Alberta, June 03, 2026 (GLOBE NEWSWIRE) -- PHX Energy" or the "Corporation") (TSX: PHX) announces that its Board of Directors (the "Board") has approved an increase to its 2026 capital expenditure program (the "Program") to $80 million, a $15 million increase from the previously announced Program.